HOME >> MEDICINE >> NEWS
Synthetic production of potential pharmaceuticals dramatically simplified by Scripps research team

Chemists are currently able to synthetically produce almost any compound, but they must typically resort to expensive, complex processes that can require dozens of individual steps. Such natural product syntheses have traditionally relied on the ubiquitous use of protecting groups, which are extra compounds chemists use to shield reactive portions of a molecule during specific stages of a synthesis scheme. The protecting groups are eventually cleaved chemically to expose the reactive portion during later chemical reactions to complete a product's synthesis. Each protecting group used adds at least two steps to a synthesis, and the groups themselves have reactivity of their own that must be controlled to prevent adverse reactions.

Protecting groups are almost always a direct result of an inability to address selectivity in synthesis, says project leader Phil Baran, a chemist with The Scripps Research Institute. It is ironic that they often add an additional layer of problems on top of the preexisting ones.

Organic chemistry textbooks have long declared that the use of protecting groups was essential in natural product synthesis. Textbooks have pointed out that avoiding protecting groups is like avoiding death and taxes, says Baran, who, along with Scripps Research Kellogg School of Science and Technology graduate students Thomas Maimone and Jeremy Richter, has now disproved the belief.

To avoid the need for protecting groups, the Baran group took an unorthodox approach. Rather than assume that reactive portions of a molecule had to be shielded during various syntheses, the researchers calculated ways to use such reactivity in an overall scheme to produce the desired final product. Baran says the reason such an approach had not been successfully developed before was likely a by-product of education. From the beginning, we were always taught that the way to solve these types of problems is to protect functionality rather than to try t
'"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
21-Mar-2007


Page: 1 2 3

Related medicine news :

1. Synthetic version of scorpion venom delivers radioactive iodine to malignant brain tumors
2. Synthetic protein eases arthritis symptoms in mice
3. Tissue engineered scaffolding allows reproduction of cartilage tissue
4. Injection of skin filler material appears to stimulate collagen production
5. PhD researcher develops inexpensive, sustainable production method in just 2 years
6. ABCB6 is key to production of heme in hemoglobin
7. BC catalyst discovery promises faster, cheaper drug production
8. Study to test drugs potential to preserve insulin production in newly diagnosed type 1 diabetics
9. Growth-factor therapy improves endothelial cell production and mobility in arterial disease
10. Liver CRP production linked to atherosclerosis
11. New insights into role of tumor necrosis factor on sex hormone production in rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... ... February 13, 2020 , ... ... sectors, committed to achieving health equity for all Americans will unveil its new ... February 26th event at the National Press Club. , The event will feature ...
(Date:2/13/2020)... ... February 13, 2020 , ... President ... year, his budget proposes substantial, damaging cuts to foreign affairs, global health, and ... development and diplomacy, slashes USAID global health programs by $3.1B, and significantly reduces ...
(Date:2/11/2020)... , ... February 11, 2020 , ... ... services and solutions, today announced its move to a new, significantly larger business ... customer base alongside significant expansion in the development of digital technology platforms. , ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... Expanded Second Edition: From Sourcing to Butchery, Mindful Meat Eating for the Modern ... by New Society Publishers, this new version brings discussions of responsible meat production, ...
(Date:2/10/2020)... ... February 10, 2020 , ... Buxton is pleased ... healthcare division. In this role, Nikki will support Buxton’s current and prospective clients ... product development. , “The healthcare industry is increasingly understanding the importance of ...
Breaking Medicine News(10 mins):
(Date:2/16/2020)... ... 16, 2020 , ... In Partnership with the Smiles for Everyone Foundation ... WA office. , A limited number of appointments are available, but there is plenty ... or to schedule an appointment, please call (509)-820-4302. , Who: Bright Now! Dental, Where: ...
(Date:2/15/2020)... ... February 14, 2020 , ... February ... between the organisms that cause inflammatory gum disease (e.g., periodontitis) and systemic inflammatory ... , offers new tools in the fight against common dental problems such as ...
(Date:2/14/2020)... ... 2020 , ... Dignitana AB , world leader in scalp cooling innovation, ... sponsor three signature events in 2020 with Susan G. Komen®. The sponsorship extends Dignitana’s ... the Cure® and MORE THAN PINK Walk® events in key Dignitana markets throughout year. ...
Breaking Medicine Technology:
Cached News: